DNA & Genetics Enhancing Speed and Scalability in Upstream Bioprocessing of Monoclonal and Bispecific AntibodiesBy adminOctober 17, 20250 Register Now Panelists: Shahram Misaghi, PhD Research Fellow, Cell Line DevelopmentProlific Machines View Bio Panelist Shahram Misaghi, PhD Shahram Misaghi,…
DNA & Genetics Genmab to Acquire Merus for $8B, Expanding Bispecific Antibody Cancer PipelineBy adminSeptember 30, 20250 Genmab has agreed to acquire Merus for approximately $8 billion, the companies said today, in a deal intended to bolster…
